Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

BACKGROUND: The development of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has dramatically improved the prognosis of patients with EGFR-mutant non-small-cell lung cancer (NSCLC). The purpose of this study is to investigate the clinical outcome with or without EGFR-TKI re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lihao, Cai, Xiaona, Chen, Didi, Ye, Xuxue, Gao, Mengdan, Lu, Lihuai, Su, Huafang, Su, Meng, Hou, Meng, Xie, Congying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938625/
https://www.ncbi.nlm.nih.gov/pubmed/31892337
http://dx.doi.org/10.1186/s13014-019-1454-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938625/
https://www.ncbi.nlm.nih.gov/pubmed/31892337
http://dx.doi.org/10.1186/s13014-019-1454-2

Ejemplares similares